Haematologic Technologies Announces John Strokis as Vice President, Quality
- Thursday, December 16, 2021, 8:40
- Finance
- Add a comment
ESSEX JUNCTION, Vt., Dec. 16, 2021 /PRNewswire/ — Haematologic Technologies (“HT”), a global leader in large molecule bioanalysis and biologic reagents, today announced the appointment of John Strokis as Vice President, Quality. John will lead quality initiatives through the next phase…
About the Author
adminasapcorp has written 42001 stories on this site.